Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Diane Wilder (NPI 1619959525)

Field	Value
Entity Type	Individual
Organization	Diane Wilder
Address	8901 Carti Way
City	Little Rock
State	AR
ZIP	72205
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	November 16, 2005

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer Medicare: lifetime Medicare revenue is $1.7M while Medicaid shows none (no Medicaid billing on file). The NPI was enumerated 2005-11-16 (approximately 21 years ago), indicating long tenure in the Medicare program and an established billing history confined to fee‑for‑service Medicare.

Revenue is highly concentrated in a small set of high-cost drug codes: the top 3 Medicare codes by revenue (J9271, J9299, J0897) account for 64.6% of the provider's total Medicare revenue. Those three codes individually generated $739.6K (44.2%), $172.8K (10.3%), and $169.6K (10.1%) respectively, so drug administration is the dominant commercial driver of this practice's Medicare billing.

The taxonomy and code mix are consistent with an office-based hematology/oncology infusion practice that administers immunotherapy and biologic agents: large volumes of J9271 (pembrolizumab), J9299 (nivolumab) and J0897 (denosumab) are paired with chemotherapy administration codes (96413, 96365, 96367, G0498) and outpatient E/M visits. This pattern indicates a care model centered on repeated IV/infusion treatments with onsite monitoring and follow‑up visits rather than primarily inpatient or surgical services.

Competitive standing for the top drug codes is mixed: J9271 shows $739.6K revenue and ranks #541 of 1841 providers nationally (70th percentile; described as typical, unremarkable volume), J9299 shows $172.8K and ranks #426 of 505 providers (16th percentile; described as typical, unremarkable volume), while J0897 shows $169.6K and ranks #1268 of 10057 (87th percentile; described as typical, unremarkable volume). In short, the provider is not an outlier market leader for pembrolizumab or nivolumab nationally but is relatively higher in denosumab use compared with peers.

Service‑mix evidence points to high ambulatory complexity: 99214 contributes 1.4K claims and $118.9K (7.1% of Medicare revenue) and ranks #4667 of 479517 providers nationally (99th percentile; labeled an extreme outlier, far above typical national volume). That extreme outlier status for 99214 suggests a sustained, high volume of moderate‑complexity established patient visits, consistent with frequent oncology follow‑up and management.

Supportive care and monitoring are substantial parts of the billing profile: J0885 (epoetin alfa) produced $79.9K and ranks #65 of 953 (93th percentile; labeled notably above typical national volume), and laboratory/monitoring codes such as 36415 (2.8K claims, $22.2K; 99th percentile, typical), 80053 (1.6K claims, $16K; 97th percentile, typical), 85025 (1.9K claims, $15.3K; 97th percentile, typical), and tumor marker tests 82378 and 86300 also appear in the top codes. This combination indicates routine hematologic support and frequent lab monitoring integrated into the practice's infusion workflows.

Operationally, infusion throughput is supported by high relative use of administration codes: 96375 ranks #144 of 5191 providers (97th percentile; notably above typical national volume), 96413 ranks #437 of 7514 (94th percentile; notably above typical national volume), and 96372 ranks #1060 of 58224 (98th percentile; notably above typical national volume). These placements, together with the large claim counts for key injectable drugs, imply the practice requires infusion capacity and staffing to manage regular IV therapies and sequential infusions in an outpatient setting.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

83 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	17,200	$40	$739.6K
J9299	Injection, nivolumab, 1 mg	7,200	$20	$172.8K
J0897	Injection, denosumab, 1 mg	9,420	$20	$169.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,380	$90	$118.9K
J1437	Injection, ferric derisomaltose, 10 mg	6,100	$20	$103.7K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	13,320	$10	$79.9K
J9264	Injection, paclitaxel protein-bound particles, 1 mg	6,300	$10	$63K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	590	$90	$51K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	2,780	$10	$22.2K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	1,600	$10	$16K

Showing 1–10 of 83

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 83 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

Diane Wilder — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

83 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	27	40	20,700	$40	$896.3K
J9299	28	30	15,660	$20	$432.9K
J1437	13	20	6,450	$20	$107.8K
J9264	10	10	9,300	$10	$96.2K
J0897	26	160	2,580	$20	$89.7K
J0885	7	40	4,070	$10	$38K
96413	25	80	380	$90	$36.6K
99214	76	4,300	130	$70	$18.8K
99233	805	960	130	$90	$18.2K
99232	885	1,450	130	$60	$14.7K

Showing 1–10 of 83

Related Providers

Other providers that share a Tax Identification Number (TIN) with Diane Wilder, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Central Arkansas Radiation Therapy Institute Inc	AR	Hematology & Oncology Physician	$0	$11M
Central Arkansas Radiation Therapy Institute Inc	AR	Radiation Oncology Physician	$6.7M	$3.6M
Kamal Patel	AR	Hematology & Oncology Physician	$5.7M	$0
Ryan Hall	AR	Hematology & Oncology Physician	$4.6M	$0
Balagopalan Nair	AR	Hematology & Oncology Physician	$4.1M	$0
Lawrence Mendelsohn	AR	Hematology & Oncology Physician	$3.4M	$0
Jamie Burton	AR	Hematology & Oncology Physician	$2.8M	$0
Kewen Jauss	AR	Hematology & Oncology Physician	$2.8M	$0
Mariann Harrington	AR	Hematology & Oncology Physician	$2.7M	$0
Appalanaidu Sasapu	AR	Hematology & Oncology Physician	$2.6M	$0

Nearby Providers

Other providers in the same ZIP code as Diane Wilder, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Arkansas For Medical Sciences	AR	General Acute Care Hospital	$0	$87.2M
University Of Arkansas For Medical Sciences	AR	Internal Medicine Physician	$0	$28.6M
University Of Arkansas For Medical Sciences	AR	Pediatrics Physician	$0	$27.6M
Arkansas Department Of Health Immunizations	AR	Public Health or Welfare Agency	$0	$19.3M
Baptist Health	AR	General Acute Care Hospital	$0	$16.4M
Arkansas Department Of Health Family Planning Clinic	AR	Public Health or Welfare Agency	$0	$15.6M
Pediatrix Medical Group Of Arkansas PA	AR	Neonatal-Perinatal Medicine Physician	$0	$14.6M
Chenal Family Therapy, Plc	AR	Mental Health Counselor	$0	$12.2M
Francis A. Allen School For Exceptional Children, Inc.	AR	Developmentally Disabled Services Day Training Agency	$0	$11.9M
Arkansas Department Of Health Std	AR	Public Health or Welfare Agency	$0	$8.4M

Diane Wilder — Billing Profile & Reimbursement Data

Sign up for Diane Wilder — Billing Profile & Reimbursement Data policy alerts

Diane Wilder — Billing Profile & Reimbursement Data

Sign up for Diane Wilder — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References